Refuna (Gefapixant)
Refractory/Unexplained Chronic Cough
MarketedActive (Lifecycle Management)
Key Facts
Indication
Refractory/Unexplained Chronic Cough
Phase
Marketed
Status
Active (Lifecycle Management)
Company
About KYORIN Pharmaceutical
KYORIN Pharmaceutical is a publicly listed Japanese pharmaceutical leader with a mission to contribute to people's health by addressing unmet medical needs. Founded in 1923 and publicly listed in 1999, the company has achieved significant scale with a market valuation of ~$94.8B, built on a foundation of established products in respiratory and urology. Its current strategy, outlined in the 'Vision 110' long-term plan, focuses on transforming its business structure to become a core innovator in new pharmaceuticals while expanding its healthcare portfolio.
View full company profile